A US generic drugs manufacturer is to create up to 300 jobs on the site of the former Johnson & Johnson site in Cashel, Co Tipperary, capping what has been a good month for regional jobs announcements.
New Jersey-based Amneal Pharmaceuticals has purchased the 60,000 sq m site from which it intends to launch its European expansion.
Amneal expects to hire between 250 and 300 employees once fully operational.
“Our new Ireland facility is critical to Amneal’s long-term growth, in Europe, the US and throughout the world,” said Amneal co-chief executive, Chintu Patel.
“We appreciate the outstanding support from IDA Ireland and others in helping us establish ourselves in County Tipperary and are excited to launch our operations here.
The Cashel site will act as a dedicated R&D hub with additional production of metered dose and dry powder inhalers.
“That Amneal has chosen to locate in a facility that had been occupied previously is especially pleasing and is a credit to the IDA executives who are advertising ready-to-go sites just like this in boardrooms across the world on a daily basis,” said IDA chief executive, Martin Shanahan.
Amneal is the seventh largest US generic drugs company by volume having been established in 2002.
The announcement caps a good month for regional job creation with ridesharing app, Uber announcing its intention earlier this week to open its first Centre of Excellence outside of the US in Limerick with the creation of 300 jobs by the end of 2016.
Earlier this month, software company Pramerica Systems announced it was creating more than 300 roles in Donegal.
© Irish Examiner Ltd. All rights reserved